Switch theme
Sign up to access all valuation multiples
Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.
1994
3.4K+
LTM Revenue $923M
LTM EBITDA $158M
$2.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Genus has a last 12-month revenue (LTM) of $923M and a last 12-month EBITDA of $158M.
In the most recent fiscal year, Genus achieved revenue of $913M and an EBITDA of $101M.
Genus expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Genus valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $923M | XXX | $913M | XXX | XXX | XXX |
| Gross Profit | $401M | XXX | $244M | XXX | XXX | XXX |
| Gross Margin | 43% | XXX | 27% | XXX | XXX | XXX |
| EBITDA | $158M | XXX | $101M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 11% | XXX | XXX | XXX |
| EBIT | $107M | XXX | $42.3M | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $65.7M | XXX | $10.8M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $260M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 16, 2025, Genus's stock price is GBP 24 (or $33).
Genus has current market cap of GBP 1.6B (or $2.2B), and EV of GBP 1.8B (or $2.5B).
See Genus trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.5B | $2.2B | XXX | XXX | XXX | XXX | $1.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 16, 2025, Genus has market cap of $2.2B and EV of $2.5B.
Genus's trades at 2.7x EV/Revenue multiple, and 19.4x EV/EBITDA.
Equity research analysts estimate Genus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Genus has a P/E ratio of 32.9x.
See valuation multiples for Genus and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.2B | XXX | $2.2B | XXX | XXX | XXX |
| EV (current) | $2.5B | XXX | $2.5B | XXX | XXX | XXX |
| EV/Revenue | 2.7x | XXX | 2.7x | XXX | XXX | XXX |
| EV/EBITDA | 15.8x | XXX | 19.4x | XXX | XXX | XXX |
| EV/EBIT | 23.4x | XXX | 33.7x | XXX | XXX | XXX |
| EV/Gross Profit | 6.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 32.9x | XXX | 56.9x | XXX | XXX | XXX |
| EV/FCF | 39.0x | XXX | 71.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialGenus's last 12 month revenue growth is 4%
Genus's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Genus's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Genus's rule of X is 27% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Genus and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 19% | XXX | XXX | XXX |
| Rule of 40 | 17% | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 27% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 22% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Hydratec Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| Brazil Potash | XXX | XXX | XXX | XXX | XXX | XXX |
| House of Agriculture | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers & Chemicals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Genus acquired XXX companies to date.
Last acquisition by Genus was XXXXXXXX, XXXXX XXXXX XXXXXX . Genus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Genus founded? | Genus was founded in 1994. |
| Where is Genus headquartered? | Genus is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Genus have? | As of today, Genus has 3.4K+ employees. |
| Who is the CEO of Genus? | Genus's CEO is Mr. Jorgen Kokke. |
| Is Genus publicy listed? | Yes, Genus is a public company listed on LON. |
| What is the stock symbol of Genus? | Genus trades under GNS ticker. |
| When did Genus go public? | Genus went public in 2000. |
| Who are competitors of Genus? | Similar companies to Genus include e.g. Fertiglobe, Hydratec Industries, Brazil Potash, House of Agriculture. |
| What is the current market cap of Genus? | Genus's current market cap is $2.2B |
| What is the current revenue of Genus? | Genus's last 12 months revenue is $923M. |
| What is the current revenue growth of Genus? | Genus revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Genus? | Current revenue multiple of Genus is 2.7x. |
| Is Genus profitable? | Yes, Genus is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Genus? | Genus's last 12 months EBITDA is $158M. |
| What is Genus's EBITDA margin? | Genus's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Genus? | Current EBITDA multiple of Genus is 15.8x. |
| What is the current FCF of Genus? | Genus's last 12 months FCF is $64.2M. |
| What is Genus's FCF margin? | Genus's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Genus? | Current FCF multiple of Genus is 39.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
